Birchview Capital, LP Veracyte, Inc. Transaction History

Birchview Capital, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$16.13 - $30.17 $173,671 - $324,840	-10,767 Closed	0 $0
Q4 2019 Feb 12, 2020	SELL	$20.78 - $29.99 $103,900 - $149,950	-5,000 Reduced 31.71%	10,767 $301,000
Q3 2019 Nov 12, 2019	SELL	$23.87 - $30.93 $358,050 - $463,950	-15,000 Reduced 48.75%	15,767 $378,000
Q2 2019 Aug 06, 2019	SELL	$22.1 - $28.56 $88,400 - $114,240	-4,000 Reduced 11.51%	30,767 $877,000
Q1 2019 May 03, 2019	SELL	$12.0 - $25.76 $168,000 - $360,640	-14,000 Reduced 28.71%	34,767 $870,000
Q3 2018 Nov 01, 2018	SELL	$9.55 - $12.64 $477,500 - $632,000	-50,000 Reduced 50.62%	48,767 $466,000
Q2 2018 Aug 02, 2018	SELL	$5.39 - $9.66 $107,800 - $193,200	-20,000 Reduced 16.84%	98,767 $922,000
Q3 2017 Nov 02, 2017	BUY	$7.81 - $8.77 $927,570 - $1.04 Million	118,767	118,767 $1.04 Million

307

81.6M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $2.97B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Birchview Capital, LP with notifications on news.